Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors

Journal of Virology

Volumn 83, Issue 19, 2009, Pages 10176-10186

  Quinn, Kathrina ^a   Brindley, Melinda A ^b   Weller, Melodie L ^a   Kaludov, Nikola ^a   Kondratowicz, Andrew ^b   Hunt, Catherine L ^b   Sinn, Patrick L ^b   McCray Jr , Paul B ^b   Stein, Colleen S ^b   Davidson, Beverly L ^b   Flick, Ramon ^c   Mandell, Robert ^c   Staplin, William ^c   Maury, Wendy ^b   Chiorini, John A ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c BioProtection Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COMPLEMENTARY DNA; GLYCOPROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS VECTOR;

ACTIN FILAMENT; ADENO ASSOCIATED VIRUS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EBOLA VIRUS; EMBRYO; ENDOCYTOSIS; GENE EXPRESSION; GENE OVEREXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MICROARRAY ANALYSIS; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; STRESS FIBER; TUMOR CELL LINE; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS ENTRY; VIRUS INFECTION; VIRUS LIKE AGENT;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; COS CELLS; EBOLAVIRUS; GENETIC VECTORS; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; PLASMIDS; RHO GTP-BINDING PROTEINS; VERO CELLS; VESICULOVIRUS;

ADENO-ASSOCIATED VIRUS - 2; EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 70349287592     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00422-09     Document Type: Article

References (49)

1. 2/M transition of HeLa cells. Mol. Biol. Cell 18:3752-3763.
2. Bishop, A. L., and A. Hall. 2000. Rho GTPases and their effector proteins. Biochem. J. 348:241-255.
3. Brindley, M. A., L. Hughes, A. Ruiz, P. B. McCray, Jr., A. Sanchez, D. A. Sanders, and W. Maury. 2007. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J. Virol. 81:7702-7709. (Pubitemid 47047855)
4. Cernescu, C., S. N. Constantinescu, and L. M. Popescu. 1990. Electron microscopic observations of vesicular stomatitis virus particles penetration in human fibroblasts. Rev. Roum. Virol. 41:93-96.
5. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
6. Chan, S. Y., C. J. Empig, F. J. Welte, R. F. Speck, A. Schmaljohn, J. F. Kreisberg, and M. A. Goldsmith. 2001. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106:117-126.
7. Chan, S. Y., R. F. Speck, M. C. Ma, and M. A. Goldsmith. 2000. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74:4933-4937. (Pubitemid 30237927)
8. Chandran, K., N. J. Sullivan, U. Felbor, S. P. Whelan, and J. M. Cunningham. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645. (Pubitemid 40807517)
9. Coil, D. A., and A. D. Miller. 2004. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J. Virol. 78:10920-10926.
10. Duan, D., Q. Li, A. W. Kao, Y. Yue, J. E. Pessin, and J. F. Engelhardt. 1999. Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73:10371-10376.
11. Empig, C. J., and M. A. Goldsmith. 2002. Association of the caveola vesicular system with cellular entry by filoviruses. J. Virol. 76:5266-5270.
12. Favoreel, H. W., L. W. Enquist, and B. Feierbach. 2007. Actin and Rho GTPases in herpesvirus biology. Trends Microbiol. 15:426-433.
13. Hall, A. 2005. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 33:891-895.
14. Hewlett, L. J., A. R. Prescott, and C. Watts. 1994. The coated pit and macropinocytic pathways serve distinct endosome populations. J. Cell Biol. 124:689-703.
15. Johnson, R. F., P. Bell, and R. N. Harty. 2006. Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virol. J. 3:31.
16. Johnston, J. C., M. Gasmi, L. E. Lim, J. H. Elder, J. K. Yee, D. J. Jolly, K. P. Campbell, B. L. Davidson, and S. L. Sauter. 1999. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73:4991-5000. (Pubitemid 29246760)
17. Just, I., G. Fritz, K. Aktories, M. Giry, M. R. Popoff, P. Boquet, S. Hegenbarth, and C. von Eichel-Streiber. 1994. Clostridium difficile toxin B acts on the GTP-binding protein Rho. J. Biol. Chem. 269:10706-10712.
18. Just, I., J. Selzer, M. Wilm, C. von Eichel-Streiber, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-503.
19. Kaletsky, R. L., G. Simmons, and P. Bates. 2007. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J. Virol. 81:13378-13384.
20. Koo, H. M., A. Monks, A. Mikheev, L. V. Rubinstein, M. Gray-Goodrich, M. J. McWilliams, W. G. Alvord, H. K. Oie, A. F. Gazdar, K. D. Paull, H. Zarbl, and G. F. Vande Woude. 1996. Enhanced sensitivity to 1-beta-D- arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res. 56:5211-5216.
21. Lakadamyali, M., M. J. Rust, and X. Zhuang. 2004. Endocytosis of influenza viruses. Microbes Infect. 6:929-936.
22. Lehmann, M. J., N. M. Sherer, C. B. Marks, M. Pypaert, and W. Mothes. 2005. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell Biol. 170:317-325.
23. Li, E., D. Stupack, G. M. Bokoch, and G. R. Nemerow. 1998. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J. Virol. 72:8806-8812. (Pubitemid 28471824)
24. Locker, J. K., A. Kuehn, S. Schleich, G. Rutter, H. Hohenberg, R. Wepf, and G. Griffiths. 2000. Entry of the two infectious forms of vaccinia virus at the plasma membrane is signaling-dependent for the IMV but not the EEV. Mol. Biol. Cell 11:2497-2511.
25. Marsh, M., and A. Helenius. 1989. Virus entry into animal cells. Adv. Virus Res. 36:107-151.
26. Marzi, A., A. Akhavan, G. Simmons, T. Gramberg, H. Hofmann, P. Bates, V. R. Lingappa, and S. Pohlmann. 2006. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J. Virol. 80:6305-6317. (Pubitemid 43927433)
27. Prendergast, G. C. 2001. Farnesyltransferase inhibitors define a role for RhoB in controlling neoplastic pathophysiology. Histol. Histopathol. 16:269-275.
28. Reed-Inderbitzin, E., and W. Maury. 2003. Cellular specificity of HIV-1 replication can be controlled by LTR sequences. Virology 314:680-695. (Pubitemid 37209984)
29. Rodriguez, L. L. 2002. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res. 85:211-219. (Pubitemid 34606915)
30. Sanchez, A. 2007. Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J. Infect. Dis. 196(Suppl. 2):S251-S258.
31. Schlegel, R., T. S. Tralka, M. C. Willingham, and I. Pastan. 1983. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32:639-646.
32. Schmidt, M., U. Rumenapp, C. Bienek, J. Keller, C. von Eichel-Streiber, and K. H. Jakobs. 1996. Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B. Role of Rho proteins. J. Biol. Chem. 271:2422-2426.
33. Schornberg, K., S. Matsuyama, K. Kabsch, S. Delos, A. Bouton, and J. White. 2006. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80:4174-4178.
34. Schowalter, R. M., M. A. Wurth, H. C. Aguilar, B. Lee, C. L. Moncman, R. O. McCann, and R. E. Dutch. 2006. Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell-cell fusion. Virology 350:323-334.
35. Shimojima, M., Y. Ikeda, and Y. Kawaoka. 2007. The mechanism of Axl-mediated Ebola virus infection. J. Infect. Dis. 196(Suppl. 2):S259-S263.
36. Shimojima, M., A. Takada, H. Ebihara, G. Neumann, K. Fujioka, T. Irimura, S. Jones, H. Feldmann, and Y. Kawaoka. 2006. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J. Virol. 80:10109-10116. (Pubitemid 44522604)
37. Sieczkarski, S. B., and G. R. Whittaker. 2002. Dissecting virus entry via endocytosis. J. Gen. Virol. 83:1535-1545.
38. Sinn, P. L., M. A. Hickey, P. D. Staber, D. E. Dylla, S. A. Jeffers, B. L. Davidson, D. A. Sanders, and P. B. McCray, Jr. 2003. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. 77:5902-5910.
39. Sullivan, N., Z. Y. Yang, and G. J. Nabel. 2003. Ebola virus pathogenesis: implications for vaccines and therapies. J. Virol. 77:9733-9737. (Pubitemid 37122053)
40. Sun, X., V. K. Yau, B. J. Briggs, and G. R. Whittaker. 2005. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 338:53-60. (Pubitemid 40835926)
41. Superti, F., L. Seganti, F. M. Ruggeri, A. Tinari, G. Donelli, and N. Orsi. 1987. Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 68:387-399.
42. Takada, A., C. Robison, H. Goto, A. Sanchez, K. G. Murti, M. A. Whitt, and Y. Kawaoka. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA 94:14764-14769.
43. Veettil, M. V., N. Sharma-Walia, S. Sadagopan, H. Raghu, R. Sivakumar, P. P. Naranatt, and B. Chandran. 2006. RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J. Virol. 80:11432-11446. (Pubitemid 44788859)
44. Wheeler, A. P., and A. J. Ridley. 2004. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp. Cell Res. 301:43-49.
45. Wool-Lewis, R. J., and P. Bates. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.
46. Wyatt, R., and J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888. (Pubitemid 28299385)
47. Yonezawa, A., M. Cavrois, and W. C. Greene. 2005. Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J. Virol. 79:918-926. (Pubitemid 40053875)
48. Zaharevitz, D. W., S. L. Holbeck, C. Bowerman, and P. A. Svetlik. 2002. COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition. J. Mol. Graph. Model. 20:297-303.
49. Zalcman, G., V. Closson, G. Linares-Cruz, F. Lerebours, N. Honore, A. Tavitian, and B. Olofsson. 1995. Regulation of Ras-related RhoB protein expression during the cell cycle. Oncogene 10:1935-1945.